(Q46832663)

25 December 2017

title

EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives (English)

1 reference

25 December 2017

amyotrophic lateral sclerosis

main subject

0 references

0 references

4

1 reference

25 December 2017

Vincenzo Silani

8

1 reference

25 December 2017

P Nigel Leigh

6

object named as

P N Leigh

1 reference

25 December 2017

P M Andersen

1

1 reference

25 December 2017

G D Borasio

2

1 reference

25 December 2017

R Dengler

3

1 reference

25 December 2017

K Kollewe

5

1 reference

25 December 2017

P-F Pradat

7

1 reference

25 December 2017

B Tomik

9

1 reference

25 December 2017

EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis

10

1 reference

25 December 2017

publication date

1 December 2005

1 reference

25 December 2017

European Journal of Neurology

published in

1 reference

25 December 2017

volume

12

1 reference

25 December 2017

issue

12

1 reference

25 December 2017

page(s)

921-938

1 reference

25 December 2017

Detection of preclinical motor neurone loss in SOD1 mutation carriers using motor unit number estimation

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Citalopram for post-stroke pathological crying

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

The effects of motor neurone disease on language: further evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

SOD1 mutations in amyotrophic lateral sclerosis. Results from a multicenter Italian study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Non-invasive ventilation in ALS: current practice and future role.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Noninvasive ventilation in ALS: indications and effect on quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Home mechanical ventilation for amyotrophic lateral sclerosis: nasal compared to tracheostomy-intermittent positive pressure ventilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Amyotrophic lateral sclerosis care in Italy: a nationwide study in neurological centers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Percutaneous radiological gastrostomy: a safe and effective method of nutritional tube placement in advanced ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Language impairment in motor neurone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Letters to patients: improving communication in cancer care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Good practice in the management of adults with malignant cerebral glioma: clinical guidelines. Working Group, Royal College of Physicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Nutritional assessment and survival in ALS patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Ultrasound-guided versus 'blind' intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

A survey of clinicians' practice in the symptomatic treatment of ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Nutritional management in MND/ALS patients: an evidence based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Management of motor neurone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Sublingual atropine for sialorrhea secondary to parkinsonism: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Copper/zinc superoxide dismutase 1 and sporadic amyotrophic lateral sclerosis: analysis of 155 cases and identification of a novel insertion mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

A systematic review of the use of opioids in the management of dyspnoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

The use of hydrotherapy for the management of spasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Prognosis of amyotrophic lateral sclerosis and the effect of referral selection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Use of intrathecal baclofen for treatment of spasticity in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

The control of oral secretions in bulbar ALS/MND.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Familial ALS in Germany: origin of the R115G SOD1 mutation by a founder effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Toward earlier diagnosis of amyotrophic lateral sclerosis: revised criteria. rhCNTF ALS Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Efficacy of mechanical insufflation-exsufflation in medically stable patients with amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

The use of opioids and sedatives at the end of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Reduction of salivary flow with transdermal scopolamine: a four-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Botulinum toxin for the treatment of sialorrhoea in ALS: serious side effects of a transductal approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Recurrent trismus and stridor in an ALS patient: successful treatment with botulinum toxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Breaking the news: A survey of ALS patients and their caregivers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Mutations in all five exons ofSOD-1 may cause ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Standards of palliative care for patients with amyotrophic lateral sclerosis: results of a European survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

Genetics of ALS in Italian families

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01351.X

10.1111/J.1468-1331.2005.01351.X

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

16324086

1 reference

25 December 2017